Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Parkinson Disease D010300 53 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Ascorbic Acid Deficiency D001206 9 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Atherosclerosis D050197 85 associated lipids
Insulin Resistance D007333 99 associated lipids
Dehydration D003681 11 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Critical Illness D016638 13 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Myocardial Stunning D017682 10 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Carcinogenesis D063646 3 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Restless Legs Syndrome D012148 2 associated lipids
Iron Overload D019190 11 associated lipids
Anemia, Refractory D000753 3 associated lipids
Calcium Metabolism Disorders D002128 1 associated lipids
Anemia, Neonatal D000751 1 associated lipids
Gilbert Disease D005878 2 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Konjiki O et al. [A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide]. 1994 Nihon Ronen Igakkai Zasshi pmid:7853746
Wada Y et al. [Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide]. 2011 Nippon Naika Gakkai Zasshi pmid:22175146
Okada M et al. [2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide]. 1982 Nippon Naika Gakkai Zasshi pmid:7166673
Okuyama T et al. [Measurement and its fluctuation of urinary glucaric acid in newborns]. 1993 Nippon Sanka Fujinka Gakkai Zasshi pmid:8340644
Mizumoto Y et al. [Measurement and fluctuation of urinary glucaric acid in pregnant women]. 1994 Nippon Sanka Fujinka Gakkai Zasshi pmid:8089594
Hartikka P et al. Effect of iron-saccharin injections of Finnish horses. 1983 May-Jun Nord Vet Med pmid:6889132
Micheletti C et al. [Enzyme induction during treatment with isoniazid]. 1978 Aug 26-Sep 2 Nouv Presse Med pmid:693296
Ballinger JR et al. Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. 2003 Nucl Med Commun pmid:12717079
Liu Z et al. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. 2004 Nucl Med Commun pmid:15208499
Liu Z et al. Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. 2008 Nucl Med Commun pmid:18094633
Petrov AD et al. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. 1997 Nucl Med Commun pmid:9106778
Gambini JP et al. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model. 2011 Nucl. Med. Biol. pmid:21315281
Isnardi V et al. Is [(99m)Tc]glucarate uptake mediated by fructose transporter GLUT-5? 2012 Nucl. Med. Biol. pmid:23084044
Saluk-Juszczak J et al. Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets. 2008 Nutr Metab Cardiovasc Dis pmid:17933501
Gonçalves P et al. The effect of high glucose on SERT, the human plasmalemmal serotonin transporter. 2008 Nutr Neurosci pmid:19000377
Kim Y et al. Combination of erythritol and fructose increases gastrointestinal symptoms in healthy adults. 2011 Nutr Res pmid:22118754
Olas B et al. Protective effects of D-glucaro 1,4-lactone against oxidative/nitrative modifications of plasma proteins. 2007 Nutrition pmid:17234507
Franco G and Fonte R Advances in evaluating liver response to operating theatre work: urinary D-glucaric acid as an index of effect. 1994 Occup Med (Lond) pmid:8167312
Kowalczyk MC et al. Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors. 2011 Oncol. Rep. pmid:21687956
Aime S et al. para-Hydrogenation of unsaturated moieties on poly(lysine) derived substrates for the development of novel hyperpolarized MRI contrast agents. 2005 Org. Biomol. Chem. pmid:16240012
Berlin I et al. [The effect of contraceptives on serum lipids, gamma glutamyl transpeptidase and D-glucaric acid elimination]. 1980 Orv Hetil pmid:6110202
Gachályi B et al. [Effect of alpha methyldopa on the mixed oxygenase system of the liver in man]. 1979 Orv Hetil pmid:372883
Roth B et al. [Excretion of D-glucaric-acid in newborns with non-hemolytic hyperbilirubinemia after phenobarbital treatment (author's transl)]. 1977 Padiatr Padol pmid:904946
Micheletti C et al. [Enzymatic induction during isoniazid therapy (author's transl)]. 1979 Pathol. Biol. pmid:392418
Auerbach M Should intravenous iron be upfront therapy for iron deficiency anemia? 2011 Pediatr Blood Cancer pmid:21298731
Crary SE et al. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. 2011 Pediatr Blood Cancer pmid:21298748
Galutira PJ and Del Rio M Understanding renal posttransplantation anemia in the pediatric population. 2012 Pediatr. Nephrol. pmid:22086345
Hörl WH Iron therapy for renal anemia: how much needed, how much harmful? 2007 Pediatr. Nephrol. pmid:17206511
Schröder CH The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. 2003 Pediatr. Nephrol. pmid:12750985
Talafant E et al. Glucaric acid excretion as index of hepatic glucuronidation in neonates after phenobarbital treatment. 1975 Pediatr. Res. pmid:1134846
Talafant E et al. Negative feedback control of neonatal serum creatine and increased urinary creatinine excretion after enzyme-inducing drugs. 1977 Pediatr. Res. pmid:887306
Gourley GR et al. The effect of saccharolactone on rat intestinal absorption of bilirubin in the presence of human breast milk. 1989 Pediatr. Res. pmid:2704588
Levy G et al. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. 1975 Pediatrics pmid:1134883
Pollak A et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. 2001 Pediatrics pmid:11134438
Hörl WH Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 Sep-Oct Perit Dial Int pmid:11757843
Dittrich E et al. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. 2002 Jan-Feb Perit Dial Int pmid:11929146
Li H and Wang SX Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. 2008 Mar-Apr Perit Dial Int pmid:18332450
Prakash S et al. Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 May-Jun Perit Dial Int pmid:11475345
PERSOONIAL Reflections. 2009 Persoonia pmid:20198167
Barot BS et al. Physicochemical and structural characterization of iron-sucrose formulations: a comparative study. 2014 Pharm Dev Technol pmid:23701359
Sane R et al. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. 2007 Pharmacotherapy pmid:17381390
Pai AB et al. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. 2007 Pharmacotherapy pmid:17316146
Arató M and Varadi A On the possible role of enzyme induction in cases of resistancy to chlorpromazine treatment. 1977 Pharmakopsychiatr Neuropsychopharmakol pmid:616930
Araki T et al. Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iron deficiency anemia. 2012 Pharmazie pmid:23346769
Centeno DC et al. Malate plays a crucial role in starch metabolism, ripening, and soluble solid content of tomato fruit and affects postharvest softening. 2011 Plant Cell pmid:21239646
Fior S and Gerola PD Impact of ubiquitous inhibitors on the GUS gene reporter system: evidence from the model plants Arabidopsis, tobacco and rice and correction methods for quantitative assays of transgenic and endogenous GUS. 2009 Plant Methods pmid:20042078
Strack D et al. Enzymic synthesis of caffeoylglucaric Acid from chlorogenic Acid and glucaric Acid by a protein preparation from tomato cotyledons. 1987 Plant Physiol. pmid:16665274
Do PT et al. The influence of fruit load on the tomato pericarp metabolome in a Solanum chmielewskii introgression line population. 2010 Plant Physiol. pmid:20841452
Sudan C et al. Ubiquitous presence of beta-glucuronidase (GUS) in plants and its regulation in some model plants. 2006 Planta pmid:16652220
Saluk-Juszczak J A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model. 2010 Platelets pmid:20873960